Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BJE6-106 (B106) is a potent, selective PKCδ inhibitor (IC50: 0.05 μM) and targets selectivity over classical PKCα (IC50: 50 μM). BJE6-106 induces caspase-dependent apoptosis with tumor-specific effect.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 262,000 |
50 mg | 約6-8 週間 | ¥ 342,000 |
100 mg | 約6-8 週間 | ¥ 532,500 |
1 mL * 10 mM (in DMSO) | 約6-8 週間 | ¥ 84,000 |
説明 | BJE6-106 (B106) is a potent, selective PKCδ inhibitor (IC50: 0.05 μM) and targets selectivity over classical PKCα (IC50: 50 μM). BJE6-106 induces caspase-dependent apoptosis with tumor-specific effect. |
ターゲット&IC50 | PKCα:50 μM, PKCδ:0.05 μM |
別名 | B106 |
分子量 | 381.47 |
分子式 | C26H23NO2 |
CAS No. | 1564249-38-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BJE6-106 1564249-38-2 Chromatin/Epigenetic Cytoskeletal Signaling PKC BJE6106 BJE-6-106 BJE6 106 B 106 B106 B-106 Inhibitor inhibitor inhibit